Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Overview of attention for article published in Journal of Clinical Oncology, July 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 public wall posts from 3 users.

JCO Original Report, "Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant…

ROR provides more prognostic information in endocrine-treated patients with ER-positive, node-negative disease than RS, with…

Purpose Risk of distant recurrence (DR) among women with estrogen receptor (ER) –positive early breast cancer is the major…

Наконец появилась первая полновесная статья в реферируемом журнале об использовании РАМ50 в исполнении NanoString (nCounter) для…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.